Benadryl is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Benadryl was owned by Johnson & Johnson from 2006 to 2023.[2]
Benadryl is an antihistamine brand introduced in 1946, the first of its kind approved in the United States. Its formulation differs by market, so the same name covers diphenhydramine in North America and other antihistamines elsewhere, which has caused confusion for travellers.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Benadryl?
⌄
The parent company of Benadryl is Kenvue, a publicly listed company headquartered in the United States.
Is Benadryl American?
⌄
Yes. Benadryl originated in the United States in 1946 and its owner, Kenvue, is also headquartered in the United States.
Since when has Kenvue owned Benadryl?
⌄
Kenvue has owned Benadryl since 23 August 2023.
Who owned Benadryl before Kenvue?
⌄
Before Kenvue, Benadryl was owned by Johnson & Johnson from 2006 until 2023.
Is Benadryl still owned by Kenvue?
⌄
Yes. As of 16 September 2026, Benadryl is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.